Fundraising Fox
60 Degrees Pharmaceuticals
NASDAQ: SXTPWashington, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into 60 Degrees Pharmaceuticals
Sign up to see every warm intro you have to 60 Degrees Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 60 Degrees Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
Founders & leadership
60 Degrees Pharmaceuticals was founded in 2022 by Geoffrey S. Dow.
Investors · 1
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$3.9M disclosed across 3 of 5 rounds · 2022–2026
- Undisclosed amountprivate placementJul 2026Source ↗
▶$1.1MraisedFeb 2025 · 4 investors · PharmaceuticalsRule 506(b)
- Geoffrey S. DowExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Sales commissions
- $91.4K
- Placement agents
- H.C.WAINWRIGHT & CO., LLC
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1MraisedFeb 2025 · 4 investors · PharmaceuticalsRule 506(b)
- Geoffrey S. DowExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Sales commissions
- $88.7K
- Placement agents
- H.C.WAINWRIGHT & CO., LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.8MraisedMay 2023 · 10 investors · PharmaceuticalsRule 506(b)
- Geoffrey S. DowExecutive Officer, Director
- Amount sold
- $1.8M
- Sales commissions
- $200.5K
- Placement agents
- WALLACHBETH CAPITAL LLC, CRAFT CAPITAL MANAGEMENT LLC
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 2
Companies working in the same space as 60 Degrees Pharmaceuticals.
In the news
Frequently asked questions
- What does 60 Degrees Pharmaceuticals do?
- 60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
- Who founded 60 Degrees Pharmaceuticals?
- 60 Degrees Pharmaceuticals was founded by Geoffrey S. Dow in 2022.
- How much funding has 60 Degrees Pharmaceuticals raised?
- 60 Degrees Pharmaceuticals has disclosed $3.9M raised across 3 of its 5 known rounds.
- Where is 60 Degrees Pharmaceuticals headquartered?
- 60 Degrees Pharmaceuticals is headquartered in Washington, US.